- Report
- September 2025
- 327 Pages
Global
From €3676EUR$4,197USD£3,190GBP
- Report
- January 2026
Global
From €4292EUR$4,900USD£3,725GBP
- Report
- January 2026
Global
From €4292EUR$4,900USD£3,725GBP
- Report
- September 2025
- 143 Pages
Global
From €3502EUR$3,999USD£3,040GBP
- Report
- March 2025
- 241 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- March 2025
- 140 Pages
Global
From €4292EUR$4,900USD£3,725GBP
- Report
- February 2026
- 296 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- January 2026
- 190 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 185 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- April 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- November 2025
- 200 Pages
Global
From €6963EUR$7,950USD£6,043GBP
- Drug Pipelines
- April 2025
- 180 Pages
Global
From €2190EUR$2,500USD£1,900GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1095EUR$1,250USD£950GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1095EUR$1,250USD£950GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1095EUR$1,250USD£950GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1095EUR$1,250USD£950GBP
- Report
- March 2025
- 183 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- January 2026
- 185 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- January 2026
- 182 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP

The Stem Cell Transplant market is a subset of the larger stem cell industry. It involves the use of stem cells to treat a variety of diseases and conditions, including cancer, blood disorders, and genetic diseases. Stem cell transplants are used to replace damaged or diseased cells with healthy ones, and can be used to treat a variety of conditions.
The stem cell transplant market is a rapidly growing field, with new treatments and technologies being developed and tested. Companies in the market are focused on developing and commercializing stem cell therapies, as well as providing services related to stem cell transplantation. These companies include Celgene, Novartis, and Osiris Therapeutics. Additionally, there are a number of smaller companies that are focused on developing and commercializing stem cell therapies, such as Athersys, Inc., and Pluristem Therapeutics. Show Less Read more